7MJS image
Deposition Date 2021-04-20
Release Date 2021-06-16
Last Version Date 2024-11-13
Entry Detail
PDB ID:
7MJS
Title:
Single-Particle Cryo-EM Structure of Major Facilitator Superfamily Domain containing 2A in complex with LPC-18:3
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.03 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:2AG3 Fab heavy chain
Chain IDs:A (auth: H)
Chain Length:240
Number of Molecules:1
Biological Source:Synthetic construct
Polymer Type:polypeptide(L)
Molecule:2AG3 Fab light chain
Chain IDs:B (auth: L)
Chain Length:217
Number of Molecules:1
Biological Source:Synthetic construct
Polymer Type:polypeptide(L)
Molecule:Major Facilitator Superfamily Domain containing 2A
Gene (Uniprot):MFSD2A
Chain IDs:C (auth: X)
Chain Length:546
Number of Molecules:1
Biological Source:Gallus gallus
Primary Citation
Structural basis of omega-3 fatty acid transport across the blood-brain barrier.
Nature 595 315 319 (2021)
PMID: 34135507 DOI: 10.1038/s41586-021-03650-9

Abstact

Docosahexaenoic acid is an omega-3 fatty acid that is essential for neurological development and function, and it is supplied to the brain and eyes predominantly from dietary sources1-6. This nutrient is transported across the blood-brain and blood-retina barriers in the form of lysophosphatidylcholine by major facilitator superfamily domain containing 2A (MFSD2A) in a Na+-dependent manner7,8. Here we present the structure of MFSD2A determined using single-particle cryo-electron microscopy, which reveals twelve transmembrane helices that are separated into two pseudosymmetric domains. The transporter is in an inward-facing conformation and features a large amphipathic cavity that contains the Na+-binding site and a bound lysolipid substrate, which we confirmed using native mass spectrometry. Together with our functional analyses and molecular dynamics simulations, this structure reveals details of how MFSD2A interacts with substrates and how Na+-dependent conformational changes allow for the release of these substrates into the membrane through a lateral gate. Our work provides insights into the molecular mechanism by which this atypical major facility superfamily transporter mediates the uptake of lysolipids into the brain, and has the potential to aid in the delivery of neurotherapeutic agents.

Legend

Protein

Chemical

Disease

Primary Citation of related structures